[Federal Register: February 6, 2003 (Volume 68, Number 25)]
[Notices]               
[Page 6182]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06fe03-83]                         


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE


Drug Enforcement Administration


 
Manufacturer of Controlled Substances; Notice of Application


    Pursuant to Sec.  1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 3, 2002, American 
Radiolabeled Chemicals, Inc., 11624 Bowling Green Drive, St. Louis, 
Missouri 63146, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:


------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)...........  I
Lysergic acid diethylamide (7315)..........  I
Dimethyltryptamine (7435)..................  I
Dihydromorphine (9145).....................  I
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Hydromorphone (9150).......................  II
Oxycodone (9143)...........................  II
Thebaine (9333)............................  II
Benzoylecgonine (9180).....................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Morphine (9300)............................  II
Oxymorphone (9652).........................  II
------------------------------------------------------------------------


    The firm plans to bulk manufacture small quantities of the listed 
controlled substances as radiolabeled compounds.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 7, 2003.


    Dated: January 27, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-2916 Filed 2-5-03; 8:45 am]

BILLING CODE 4410-09-M